Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging

Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging

Abstract Introduction For early detection of Alzheimer's disease (AD), the field needs biomarkers that can be used to detect disease status with high sensitivity and specificity. Apolipoprotein J (ApoJ, also known as clusterin) has long been associated with AD pathogenesis through various pathw...

Full description

Bibliographic Details
Main Authors: Veer Bala Gupta, James D. Doecke, Eugene Hone, Steve Pedrini, Simon M. Laws, Madhav Thambisetty, Ashley I. Bush, Christopher C. Rowe, Victor L. Villemagne, David Ames, Colin L. Masters, Stuart Lance Macaulay, Alan Rembach, Stephanie R. Rainey‐Smith, Ralph N. Martins, AIBL Research Group
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Biomarkers
Apolipoprotein J
Plasma
Brain amyloid beta
Hippocampus volume
Online Access:https://doi.org/10.1016/j.dadm.2015.12.001

Internet

https://doi.org/10.1016/j.dadm.2015.12.001

Similar Items